Date: Wednesday, May 8th, 2013 9:30am-5:00pm
Location: Morgan, Lewis & Bockius Conference Center, 1111 Pennsylvania Ave., NW Washington, DC 20004-2541
National Brain Tumor Society is bringing together brain tumor researchers and industry executives to discuss how to move research from bench to bedside.
- Biophrama executives and VC investors will share their criteria for investment and licensing of academic research.
- Panelists include:
- Lauren Abrey
Global Development Team Lead, Genetech/Roche - Neil Exter
Partner, Third Rock - Brian Gallagher
Partner, SROne - Michael Glutch
Managing Director, Medimmune Ventures - Perry Nisen
Senior VP of Science Transactions, Pfizer
- Lauren Abrey
- Nation Brain Tumor Society-funded researchers will present brain tumor drug candidates ready for early stage investment and/or licensing.
{iframe}http://nbts.eventbrite.com/{/iframe}